值得一提的是，这是白宫为降低美国民众医疗成本而与制药企业达成的第二项重大协议。美国制药商辉 瑞(PFE.US)上周与特朗普政府也达成了类似的协议，将采取多项措施降低美国药品价格，并获得了三年 的药品关税豁免——前提是该公司需进一步加大在美国本土的生产投资。据悉，辉瑞计划投资700亿美 元，用于回流美国本土的药品生产及研发设施建设。 与特朗普政府同辉瑞达成的协议类似，阿斯利康将大幅下调药品价格，以换取制药业关税的三年豁免 期。该公司在美国推出的所有新药价格将与可比国家中的最低水平保持一致。此外，该公司还将以大幅 折扣价格向针对低收入及残障人士的Medicaid医保项目供应药品。这家英国制药商还将扩大其直销网 站"AstraZeneca Direct"销售的产品，以特朗普口中"大幅降低"的价格进行销售，并将在TrumpRx网站上 提供这些药品。 阿斯利康首席执行官Pascal Soriot表示，作为协议的一部分，该公司将免于制药行业的关税。阿斯利康 今年7月曾表示，到2030年将在美国投资500亿美元。 目前该协议的财务影响尚不明确。由于阿斯利康在美国销售的药品大多在当地生产，因此其受到的关税 威胁相对有限。今年 ...

“`htmlAh, the stock market. A bastion of calm, predictable rationality. Or, at least, it was before the former (and potentially future) President Donald J. Trump decided his preferred method of economic policy dissemination would be, once again, his personal social media platform, Truth Social. On October 10th and 11th, 2025, the financial world was treated to a masterclass in market-moving pronouncements, proving that a single post can still send algorithms into a tailspin and wipe billions off the books f ...

Core Points - The Trump administration has reached a deal with AstraZeneca to reduce drug prices for Americans in exchange for tariff relief, marking a significant move to lower healthcare costs [1][3] - AstraZeneca will offer major discounts on its prescription drugs and launch new medicines in the US at the lowest prices available globally [2][3] - The deal follows a similar agreement with Pfizer and is part of a broader strategy to encourage pharmaceutical companies to lower prices and increase domestic production [5][10] Company-Specific Summary - AstraZeneca will provide steep discounts on its medicines, including popular drugs like Farxiga and Airsupra, which could see price reductions of up to 70% [8][9] - The company is expanding its direct-to-consumer sales platform, AstraZeneca Direct, to offer discounted prices directly to patients [4][8] - AstraZeneca's best-selling drug, Farxiga, generated $7.7 billion in sales last year, and its pricing is already set to decrease due to upcoming Medicare negotiations [9] Industry Context - The deal is part of the Trump administration's efforts to implement most-favored nation pricing, which would require US drug prices to be equivalent or lower than those in other countries [13] - Historically, Americans have paid the highest drug prices globally, which has positioned the US as a key market for pharmaceutical innovation [12] - The financial implications of these deals are still uncertain, but initial investor fears regarding the impact of tariffs and pricing rules have lessened as commitments from drugmakers have been perceived as manageable [14]

Core Points - The United Kingdom is set to offer Americans significant discounts on prescription drugs, implementing a "most favored nation" pricing clause, which means Americans will pay the lowest price available globally [1] - AstraZeneca has committed to providing all prescription medications to Medicaid at these most favored nation prices, potentially saving American taxpayers hundreds of millions of dollars annually [6] - AstraZeneca will also invest $50 billion in the U.S. over the next five years for drug research and development, as well as onshore manufacturing facilities, creating approximately 3,600 jobs [11] Company and Industry Summary - Americans have historically paid the highest prices for prescription drugs compared to other countries, prompting the need for reforms [5] - The announcement includes a specific example of a 654% price reduction for certain inhalers and diabetic medications, indicating substantial potential savings for consumers [9] - AstraZeneca's commitment to list popular drugs online at a dedicated website further enhances transparency and accessibility for consumers [8] - The investment in U.S. manufacturing and R&D by AstraZeneca aligns with broader efforts to lower healthcare costs and improve drug availability [11][15]

the president there taking a lot of questions and a very long pro conference on a whole range of topics. But the headline was really about the war between Gaza and Israel right now with a peace treaty and the president saying 28 hostage bodies uh remain in captivity but all hostages should be released on Monday. Let's go to Yamish Alendor who's at the White House.And Yamish, the the president says um Astroenica uh the drug company is sell drugs directly to Medicaid patients at the lowest price offered in an ...

Astroenica, the largest pharmaceutical manufacturer in the United Kingdom, is committing to offer Americans major discounts on their vast catalog of prescription drugs. One of the great companies, by the way, and a most favored nation's pricing clause. So, most favored nation is uh you're going to pay whatever the lowest price anywhere in the world is.That's what you're going to be paying. ...

Melissa Astroenetica is now the second drug maker to sign on to President Trump's most favored nation drug price program. According to our colleagues at MSNBC reported it earlier. It comes after breaking ground on a $4.5% billion plant in Virginia yesterday where Dr.. Oz was present. CMS administrator Dr. . Oz very much at the center of a lot of these negotiations.And it also comes 10 days after the Fizer agreement to provide drugs. uh at lower prices for Medicaid as well as making a $70 billion investment ...

Core Insights - Melissa Astroenetica has become the second pharmaceutical company to join President Trump's most favored nation drug price program, following the establishment of a $4.5 billion plant in Virginia [1] - The agreement with Fizer, which includes a $70 billion investment in the US and lower drug prices for Medicaid, was reached just 10 days prior, allowing Fizer to avoid tariffs for three years [2] - The goal of the administration is to align 95% of US drug prices with those in Europe, indicating ongoing negotiations with various firms [3] Company Developments - The specifics of the agreement with Astroenetica are not yet clear, but it is part of a broader strategy that includes negotiations with Medicare [4] - The CMS administrator has indicated that aggressive negotiations are ongoing, with the next round of IRA price negotiations expected next month [5]

President Donald Trump is moving fast with his direct-to-customer pharmaceutical venture. On Friday, he shared from the Oval Office that he struck a deal with AstraZeneca to offer the US a "most-favored-nation" drug pricing policy that would lower prescription costs.As part of the deal, AstraZeneca has pledged to invest $50 billion in the US over the next five years in research and development of new drugs and onshore manufacturing. The company has also committed to offering prices to Medicaid patients tha ...

U.S. President Donald Trump announced an agreement with AstraZeneca on Friday where the drugmaker will offer its catalog of prescription drugs to the United States at a discounted price. ...